These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 27553866)

  • 1. The International development of PROQOL-HCV: An instrument to assess the health-related quality of life of patients treated for Hepatitis C virus.
    Armstrong AR; Herrmann SE; Chassany O; Lalanne C; Da Silva MH; Galano E; Carrieri PM; Estellon V; Sogni P; Duracinsky M
    BMC Infect Dis; 2016 Aug; 16(1):443. PubMed ID: 27553866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development of PROQOL-HIV: an international instrument to assess the health-related quality of life of persons living with HIV/AIDS.
    Duracinsky M; Herrmann S; Berzins B; Armstrong AR; Kohli R; Le Coeur S; Diouf A; Fournier I; Schechter M; Chassany O
    J Acquir Immune Defic Syndr; 2012 Apr; 59(5):498-505. PubMed ID: 22205438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-related stigma and physical symptoms have a persistent influence on health-related quality of life in Australians with HIV infection.
    Herrmann S; McKinnon E; Hyland NB; Lalanne C; Mallal S; Nolan D; Chassany O; Duracinsky M
    Health Qual Life Outcomes; 2013 Apr; 11():56. PubMed ID: 23566318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatigue and health-related quality of life (HRQL) in chronic hepatitis C virus infection.
    Kallman J; O'Neil MM; Larive B; Boparai N; Calabrese L; Younossi ZM
    Dig Dis Sci; 2007 Oct; 52(10):2531-9. PubMed ID: 17406828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychometric evaluation of the hepatitis C virus patient-reported outcomes (HCV-PRO) instrument: validity, responsiveness, and identification of the minimally important difference in a phase 2 clinical trial.
    Anderson RT; Baran RW; Erickson P; Revicki DA; Dietz B; Gooch K
    Qual Life Res; 2014 Apr; 23(3):877-86. PubMed ID: 24036634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal clinically important differences in health-related quality of life after treatment with direct-acting antivirals for chronic hepatitis C: ANRS CO22 HEPATHER cohort (PROQOL-HCV).
    Abbas M; Patrizia C; Fabienne M; Marc B; Lucia P; Fabrice C; Martin D; Camelia P
    Qual Life Res; 2024 Jun; 33(6):1527-1540. PubMed ID: 38580786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life and severity of fatigue in HIV/HCV co-infected patients before, during, and after antiviral therapy with pegylated interferon plus ribavirin.
    Mandorfer M; Payer BA; Scheiner B; Breitenecker F; Aichelburg MC; Grabmeier-Pfistershammer K; Rieger A; Trauner M; Peck-Radosavljevic M; Reiberger T
    Liver Int; 2014 Jan; 34(1):69-77. PubMed ID: 23890125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychometric validation of the PROQOL-HIV questionnaire, a new health-related quality of life instrument-specific to HIV disease.
    Duracinsky M; Lalanne C; Le Coeur S; Herrmann S; Berzins B; Armstrong AR; Lau JT; Fournier I; Chassany O
    J Acquir Immune Defic Syndr; 2012 Apr; 59(5):506-15. PubMed ID: 22293550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life, risk behaviors and depression among carriers of hepatitis C virus and human T-cell lymphotropic virus type 1: a comparative study.
    Henrique-Araújo R; Quarantini LC; Caribé AC; Argolo FC; Jesus-Nunes AP; Morais-de-Jesus M; Dantas-Duarte A; Moreira TM; Oliveira IR
    Braz J Infect Dis; 2019; 23(4):224-230. PubMed ID: 31344356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous and post-treatment HCV clearance: relationships with health-related quality of life in HIV infection (ANRS-VESPA2 study).
    Marcellin F; Demoulin B; Spire B; Suzan-Monti M; Roux P; Protopopescu C; Sagaon-Teyssier L; Duracinsky M; Dray-Spira R; Carrieri MP;
    Expert Rev Gastroenterol Hepatol; 2015 May; 9(5):701-13. PubMed ID: 25723557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a modified Berger HIV stigma scale for use among patients with hepatitis C virus (HCV) infection.
    Saine ME; Moore TM; Szymczak JE; Bamford LP; Barg FK; Mitra N; Schnittker J; Holmes JH; Lo Re V
    PLoS One; 2020; 15(2):e0228471. PubMed ID: 32023310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance and Validation of Chronic Liver Disease Questionnaire-Hepatitis C Version (CLDQ-HCV) in Clinical Trials of Patients with Chronic Hepatitis C.
    Younossi ZM; Stepanova M; Henry L
    Value Health; 2016; 19(5):544-51. PubMed ID: 27565271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of health-related quality of life and work productivity in chronic hepatitis C patients with early and advanced fibrosis treated with ledipasvir and sofosbuvir.
    Younossi ZM; Stepanova M; Afdhal N; Kowdley KV; Zeuzem S; Henry L; Hunt SL; Marcellin P
    J Hepatol; 2015 Aug; 63(2):337-45. PubMed ID: 25795586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and initial psychometric evaluation of the hepatitis C virus-patient-reported outcomes (HCV-PRO) instrument.
    Anderson RT; Baran RW; Dietz B; Kallwitz E; Erickson P; Revicki DA
    Qual Life Res; 2014 Mar; 23(2):561-70. PubMed ID: 24005885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health related quality of life among patients with chronic hepatitis C: a cross-sectional study of sociodemographic, psychopathological and psychiatric determinants.
    Fábregas BC; de Ávila RE; Faria MN; Moura AS; Carmo RA; Teixeira AL
    Braz J Infect Dis; 2013; 17(6):633-9. PubMed ID: 23916456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of Life and Social Functioning during Treatment of Recent Hepatitis C Infection: A Multi-Centre Prospective Cohort.
    Doyle JS; Grebely J; Spelman T; Alavi M; Matthews GV; Thompson AJ; Dore GJ; Hellard ME;
    PLoS One; 2016; 11(6):e0150655. PubMed ID: 27355323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life, depression and fatigue among persons co-infected with HIV and hepatitis C: outcomes from a population-based cohort.
    Braitstein P; Montessori V; Chan K; Montaner JS; Schechter MT; O'Shaughnessy MV; Hogg RS
    AIDS Care; 2005 May; 17(4):505-15. PubMed ID: 16036236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative impact of fatigue and subclinical cognitive brain dysfunction on health-related quality of life in chronic hepatitis C infection.
    Kramer L; Hofer H; Bauer E; Funk G; Formann E; Steindl-Munda P; Ferenci P
    AIDS; 2005 Oct; 19 Suppl 3():S85-92. PubMed ID: 16251834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A reduced factor structure for the PROQOL-HIV questionnaire provided reliable indicators of health-related quality of life.
    Lalanne C; Chassany O; Carrieri P; Marcellin F; Armstrong AR; Lert F; Spire B; Dray-Spira R; Duracinsky M
    J Clin Epidemiol; 2016 Apr; 72():116-25. PubMed ID: 26548542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.